Advertisement

Topics

Bluebird bio prices beta thalassaemia gene therapy Zynteglo at 1.575 million euros over five years https://firstwordpharma.com/node/1647549?tsid=28®ion_id=6 …

10:47 EDT 14 Jun 2019 | FirstWord Pharma

Bluebird bio prices beta thalassaemia gene therapy Zynteglo at 1.575 million euros over five years https://firstwordpharma.com/node/1647549?tsid=28&region_id=6 …

Original Article: Bluebird bio prices beta thalassaemia gene therapy Zynteglo at 1.575 million euros over five years https://firstwordpharma.com/node/1647549?tsid=28®ion_id=6 …

NEXT ARTICLE

More From BioPortfolio on "Bluebird bio prices beta thalassaemia gene therapy Zynteglo at 1.575 million euros over five years https://firstwordpharma.com/node/1647549?tsid=28®ion_id=6 …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...